These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38833877)

  • 1. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.
    Son DH; Kwon YJ; Lee JH
    J Nutr Health Aging; 2024 Jun; 28(6):100270. PubMed ID: 38833877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    Mai Z; Chen Y; Mao H; Wang L
    J Diabetes; 2024 Jun; 16(6):e13569. PubMed ID: 38751375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
    Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population.
    Liu C; Li N; Sheng D; Shao Y; Qiu L; Shen C; Liu Z
    Lipids Health Dis; 2024 Apr; 23(1):104. PubMed ID: 38616253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between metabolic dysfunction-associated steatotic liver disease and myosteatosis measured by computed tomography.
    Kim MJ; Cho YK; Kim EH; Lee MJ; Lee WJ; Kim HK; Jung CH
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1942-1952. PubMed ID: 39011807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between muscle mass index and LDL cholesterol target levels: Analysis of two studies of the Korean population.
    Lee JH; Lee HS; Cho AR; Lee YJ; Kwon YJ
    Atherosclerosis; 2021 May; 325():1-7. PubMed ID: 33857762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between long working hours and metabolic dysfunction-associated steatotic liver disease: a nationwide population-based study in Korea.
    Baek SU; Won JU; Lee YM; Yoon JH
    Public Health; 2024 Jul; 232():188-194. PubMed ID: 38796916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis.
    Li X; He J; Sun Q
    Clin Nutr; 2024 Sep; 43(9):2005-2016. PubMed ID: 39053329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population.
    Liu S; He Y; Yu G; Song C; Wang D; Liu L; Liang H; Wan H; Shen J
    Ann Med; 2024 Dec; 56(1):2390169. PubMed ID: 39129458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.
    Kang DE; Oh SN
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
    Martínez-Domínguez SJ; García-Mateo S; Gargallo-Puyuelo CJ; Gallego-Llera B; Callau P; Mendi C; Arroyo-Villarino MT; Simón-Marco MÁ; Ampuero J; Gomollón F
    Inflamm Bowel Dis; 2024 Aug; 30(8):1274-1283. PubMed ID: 37607330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations between Healthy Eating Patterns and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study.
    Huang X; Gan D; Fan Y; Fu Q; He C; Liu W; Li F; Ma L; Wang M; Zhang W
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease.
    Min Y; Wei X; Wei Z; Song G; Zhao X; Lei Y
    Cardiovasc Diabetol; 2024 Jun; 23(1):188. PubMed ID: 38824550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
    Hong KS; Kim MC; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
    Perumpail BJ; Manikat R; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
    J Pediatr Gastroenterol Nutr; 2024 Jul; 79(1):110-118. PubMed ID: 38623942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey.
    Hong J; Shin WK; Lee JW; Kim Y
    Metab Syndr Relat Disord; 2021 Oct; 19(8):452-459. PubMed ID: 34255575
    [No Abstract]   [Full Text] [Related]  

  • 18. Overall and Sex-Specific Associations of Serum Lipid-Soluble Micronutrients with Metabolic Dysfunction-Associated Steatotic Liver Disease among Adults in the United States.
    Chai W; Tao MH
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.
    Pan Z; Derbala M; AlNaamani K; Ghazinian H; Fan JG; Eslam M
    Ann Hepatol; 2024; 29(5):101512. PubMed ID: 38710473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
    Paik JM; Duong S; Zelber-Sagi S; Lazarus JV; Henry L; Younossi ZM
    Am J Gastroenterol; 2024 Jun; 119(6):1089-1101. PubMed ID: 38477467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.